Business & Finance
Angiotech Pharmaceuticals reports income of $0.19 per share
Published in Pharma Investments, Ventures and Law Weekly, December 10th, 2006
During the third quarter, Angiotech discontinued certain operations as part of the ongoing integration efforts related to the acquisition of American Medical Instruments Holdings, Inc., (AMI) completed in March 2006. Total revenue generated by these discontinued operations amounted to $2.9 million during the third quarter. Operating income generated by these discontinued operations during the quarter was not material. Revenues and expenses related to these discontinued operations are not...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Business & Finance
Connetics reports third quarter financial results - Business & Finance
Cross Country Healthcare reports $162.9 million for third quarter 2006 - Business & Finance
Cutera reports 32% third-quarter revenue increase over same period last year - Business Update
China Medical Technologies and Chinese Academy of Sciences Institute of Acoustics form lab - Business Update
Drager Medical and Masimo announce expanded relationship - Business Update
EDS selected to support anti-fraud program at Centers for Medicare & Medicaid Services - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
